Entrada Therapeutics Inc expected to post earnings of 14 cents a share - Earnings Preview

Entrada Therapeutics

02/08/2024 18:27

* Entrada Therapeutics Inc  TRDA.OQ   TRDA.O  is expected
to show
a rise in quarterly revenue when it reports  results on August 6
(estimated) for the period ending June 30 2024
    * The Boston Massachusetts-based  company is expected to
report a
153.6% increase in revenue to $46.075 million from $18.17
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Entrada Therapeutics Inc
is
for earnings of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Entrada
Therapeutics Inc is $21.50​, above​ its last closing price
of $15.96. ​​​

This summary was machine generated August 2 at 17:27 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)